Chronic Hepatitis Genotype-1 Relapse

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-12-19
Clinical Trial Update: Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients [Phase 2]
Phase 2 adaptive-dose finding trial assessing NIM811 with standard of care in relapsed hepatitis C genotype-1 patients; study completed.